lobbying_activities: 3390236

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3390236	16786fdc-dff3-4efa-90dc-afe25d83fdf5	Q2	TEVA PHARMACEUTICALS USA, INC.	76695	TEVA PHARMACEUTICALS USA INC	2025	second_quarter	TAR	A joint resolution terminating the national emergency declared to impose duties on articles imported from Canada (S.J.Res.37).	Commerce, Dept of (DOC),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR)		1390000	0	0	2025-07-17T17:11:24-04:00